维普中文期刊产品整合服务
24篇 您的检索式:作者名="TOMLINSON DC"
    题名 作者 年代 出处 被引量
1Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplilleation 显示文摘Hurst CD Tomlinson DC Williams SV 2007Oneogene2007,27,19:1
2Fibroblast growthfactor receptor 1 promotes proliferation and survival via activationof the mitogen-activated protein kinase pathway in bladder cancer显示文摘Tomlinson DC Lamont FR Shnyder SD 2009Cancer Res2009,69,11:1
3FGFR3 and RAS gene mutations are mutually exclusive genetic e- vents in urothelial cell carcinoma 显示文摘Jebar AH Hurst CD Tomlinson DC 2005Oncogene2005,24,33:1
4Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo 显示文摘Lamont FR Tomlinson DC Cooper PA 2011Br J Cancer2011,104,1:1
5A decade of FGF receptor research in bladder cancer:past,present,and future challenges显示文摘Di Martino E Tomlinson DC Knowles MA 2012Adv Urol2012,2012,42:1
6Differential effects of transforming growth factor-1 on cellular proliferation in the developing prostate显示文摘Tomlinson DC Freestone SH Grace OC 2004Endocrinology2004,145,:1
7Inactivation of the Rb pathway and over expression of both isoforms of E2F3 are obligate events in bladder tumors with 6p22 amplification 显示文摘Hurst CD Tomlinson DC Williams SV 2008Oncogene2008,27,19:1
8Small molecule FGF receptor inhibitors block FGFR-dependent urothe- lial carcinoma growth in vitro and in vivo显示文摘LAMONT FR TOMLINSON DC COOPER PA 2011Br J Cancer2011,104,:1
9Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast grow-th factor - induced proliferation and is repressed in urothelial carcinoma cell lines显示文摘Tomlinson DC LHote CG Kennedy W Pitt E Knowles MA 2005Cancer Res2005,65,10:1
10A decade of FGF recep?tor research in bladder cancer: past, present, and future challenges显示文摘di Martino E Tomlinson DC Knowles MA 2012Adv Urol2012,2012,42:1
11Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification显示文摘Hurst CD Tomlinson DC Williams SV 2008Oncogene2008,27,:1
12Small molecule FGF receptor inhibitors block FGFR - dependent urothelial carci- noma growth in vitro and in vivo显示文摘Lamont FR Tomlinson DC Cooper PA 2011Br J Cancer2011,104,1:1
13FGFR1 promotes pro- liferation and survival via activation of the MAPK pathway in bladder cancer显示文摘Tomlinson DC Lamont FR Shnyder SD 2009Cancer Res2009,69,11:1
14FGFR3 protein expression and its relationship tomutation status and prognostic variables in bladder cancer显示文摘Tomlinson DC Baldo O Harnden P 2007J Pathol2007,213,1:1
15Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification 显示文摘Hurst CD Tomlinson DC Williams SV 2005Oncogene2005,27,19:1
16Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification显示文摘Hurst CD Tomlinson DC WilliamsSV 2008Oncogene2008,27,19:1
17Knockdown by shRNA identifies S249Cmutant FGFR3 as a potential therapeutic target in bladder cancer显示文摘Tomlinson DC Hurst CD KnowlesmA 2007Oncogene2007,26,40:1
18Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are ob-ligate events in bladder tumours with 6p22 amplification显示文摘Hurst CD Tomlinson DC Williams SV 2008Oncogene2008,27,19:1
19Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo显示文摘Lamont FR Tomlinson DC Cooper PA 0,,01:1
20Muhidrug-resistant breast cancer: current perspectives 显示文摘Martin HL Smith L Tomlinson DC 2014Breast Cancer2014,10,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费